Copertina

Population Pharmacokinetics and Exposure‐Response Relationship of Zimberelimab in Chinese Patients with Advanced Tumors

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Fang Yang, Yongying Lu, Lihui Bai, Chenhui Deng, Zhen Liu, Zhihua Sun, Li Li, Shicong Wang, Li Zhou, Haifeng Feng, Shaoyu Yan, Jiman Zhu
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Clinical Pharmacology in Drug Development
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Population Pharmacokinetics of Butylphthalide Injection in Elderly Chinese Patients With Ischemic Stroke
di: Shu‐Xian Lyu, et al.
Pubblicazione: (2025)

Effect of Erdafitinib on the Pharmacokinetics of Midazolam and Metformin in Patients With Advanced Solid Tumors Harboring FGFR Gene Alterations
di: Wei Zhu, et al.
Pubblicazione: (2024)

Comparative Pharmacokinetics and Bioequivalence Assessment of Metformin/Pioglitazone Tablet in Fasting and Fed Conditions: A Randomized Study in Healthy Chinese Subjects
di: Hongcheng Li, et al.
Pubblicazione: (2026)

Population Pharmacokinetics Modeling and Simulation of Deutenzalutamide, A Novel Androgen Receptor Antagonist, in Patients With Metastatic Castration‐Resistant Prostate Cancer
di: Yixian Liu, et al.
Pubblicazione: (2024)

Pharmacokinetic and Bioequivalence Evaluation of Ulipristal Acetate in Healthy Chinese Subjects in the Fasting and Postprandial Conditions
di: Ling He, et al.
Pubblicazione: (2025)

Pharmacokinetics, Bioequivalence, and Safety of Bromocriptine Mesylate Tablets in Healthy Chinese Subjects
di: Huan Song, et al.
Pubblicazione: (2025)

Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Voriconazole Tablets in Healthy Chinese Volunteers
di: Pan Luo, et al.
Pubblicazione: (2026)

Comparison of the Pharmacokinetics of Three Budesonide Formulations in Healthy Chinese Subjects
di: Tengrui Yin, et al.
Pubblicazione: (2025)

Pharmacokinetics, Bioequivalence, and Safety of Levothyroxine Sodium Tablets in Healthy Chinese Subjects
di: Juan Jin, et al.
Pubblicazione: (2025)

Comparative Pharmacokinetics and Bioequivalence of Two Sodium Valproate Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions
di: Yuan Liu, et al.
Pubblicazione: (2025)

Pharmacokinetics and Safety of Linezolid Tablets of 2 Different Manufacturers in Healthy Chinese Subjects in Fasting and Fed States
di: Hanjing Chen, et al.
Pubblicazione: (2024)

Population Pharmacokinetics of Fasinumab in Healthy Volunteers and Patients With Pain Due to Osteoarthritis of the Knee or Hip
di: Kuan‐Ju Lin, et al.
Pubblicazione: (2024)

Safety, Tolerability, and Pharmacokinetics of Galcanezumab, an Anti‐CGRP Antibody, in Healthy Chinese Participants
di: Jingjing Wang, et al.
Pubblicazione: (2025)

Effect of High‐Fat Food on the Pharmacokinetics and Safety of Amlodipine/Benazepril in Healthy Chinese Participants
di: Congyang Ding, et al.
Pubblicazione: (2026)

Pharmacokinetics, Bioequivalence, and Safety of Diclofenac Sodium Sustained‐Release Tablets in Healthy Chinese Subjects Under Fasting and Fed Conditions
di: Biao Sun, et al.
Pubblicazione: (2026)

Pharmacokinetics and Bioequivalence of Vardenafil Hydrochloride in Healthy Chinese Volunteers
di: Sheng He, et al.
Pubblicazione: (2024)

Pharmacokinetic and Bioequivalence Evaluation of Dihydroxyaluminum Aminoacetate, Heavy Magnesium Carbonate, and Aspirin Tablets in Healthy Chinese Subjects in the Fasting and Postprandial Conditions
di: Fang Yao, et al.
Pubblicazione: (2024)

Population Pharmacokinetics of Naloxegol in Pediatric Subjects Receiving Opioids
di: Matthew W. Hruska, et al.
Pubblicazione: (2024)

Pharmacokinetics, Safety, and Tolerability of Cedirogant in Healthy Japanese and Chinese Adults
di: Mohamed‐Eslam F Mohamed, et al.
Pubblicazione: (2024)

Bioequivalence and Pharmacokinetic Evaluation of Regorafenib Tablets in Healthy Chinese Volunteers
di: Zhaoyu Wang, et al.
Pubblicazione: (2024)

Pharmacokinetics and Bioequivalence of Two Formulations of Valsartan and Amlodipine Tablets in Healthy Chinese Volunteers Under Fasting and Fed Conditions
di: Yu‐Ying Xu, et al.
Pubblicazione: (2025)

Pharmacokinetics and Bioequivalence of 2 Oral Formulations of Vildagliptin in Healthy Chinese Subjects
di: Mengli Tian, et al.
Pubblicazione: (2024)

Exposure–Response Analysis for Aripiprazole Once‐Monthly in Patients Diagnosed With Bipolar I Disorder
di: Xiaofeng Wang, et al.
Pubblicazione: (2025)

A Population Pharmacokinetic Assessment of the Effect of Food on Selumetinib in Patients with Neurofibromatosis Type 1‐Related Plexiform Neurofibromas and Healthy Volunteers
di: Peiying Zuo, et al.
Pubblicazione: (2024)

Comparability of Elezanumab Safety, Tolerability, and Pharmacokinetics in Healthy Japanese, Chinese, and White Participants
di: Hari V. Kalluri, et al.
Pubblicazione: (2024)

Bioequivalence and Pharmacokinetic Evaluation of Gliclazide Modified‐Release Tablets in Healthy Chinese Volunteers
di: Kejia Fu, et al.
Pubblicazione: (2026)

A Randomized, Open‐Label, Two‐Sequence, Crossover Trial Evaluating the Bioequivalence, and Pharmacokinetics of Two Sulfamethoxazole/Trimethoprim Tablet Formulations in Healthy Chinese Volunteers Under Fasting Conditions
di: Xueqiong Peng, et al.
Pubblicazione: (2025)

Effect of Cytochrome P450 3A Inhibition and Induction by Itraconazole and Rifampin on Tazemetostat Pharmacokinetics in Patients With Advanced Malignancies
di: Yingxue Chen, et al.
Pubblicazione: (2025)

Meta‐Analysis of Noncompartmental Pharmacokinetic Parameters to Evaluate the Impact of CYP2C19 and CYP2C9 Genetic Polymorphisms on Abrocitinib Exposure
di: Luke Fostvedt, et al.
Pubblicazione: (2024)

Safety, Tolerability, and Pharmacokinetics of the Long‐Acting SARS‐CoV‐2–Neutralizing Monoclonal Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) in Healthy Chinese Adults
di: Nanyang Li, et al.
Pubblicazione: (2025)

Pharmacokinetics and Bioequivalence Evaluation of Trazodone Hydrochloride Sustained‐Release Tablets in Healthy Chinese Volunteers
di: Jingyan Wang, et al.
Pubblicazione: (2024)

Safety, Tolerability, and Pharmacokinetics of Voriconazole for Injection in Two Preparations in Chinese Healthy Adult Volunteers
di: Jin Yu, et al.
Pubblicazione: (2024)

Evaluation of Acarbose Bioequivalence in Healthy Chinese Populations Using Novel Pharmacodynamic End Points
di: Linling Que, et al.
Pubblicazione: (2024)

Pharmacokinetics and Safety Evaluation of a New Generic Sitafloxacin: A Phase I Bioequivalence Study in Healthy Chinese Participants
di: Yongfang Lei, et al.
Pubblicazione: (2025)

Physiologically Based Pharmacokinetic Absorption Model for Pexidartinib to Evaluate the Impact of Meal Contents and Intake Timing on Drug Exposure
di: Shintaro Nakayama, et al.
Pubblicazione: (2024)

Pharmacokinetics and Tolerability of Entacapone, Levodopa, and Carbidopa Tablets in Healthy Chinese Subjects: A Randomized, Open‐Label, Four‐Period Crossover Study Under Fasting and Fed Conditions
di: Jingyan Wang, et al.
Pubblicazione: (2026)

The Safety, Tolerability, and Pharmacokinetics of Active Ingredients From Hydroxysafflor Yellow A in Healthy Chinese Volunteers
di: Xiuli Zhao, et al.
Pubblicazione: (2024)

Pharmacokinetics and bioequivalence of acetylcysteine granules among Chinese healthy volunteers under fasting and postprandial conditions
di: Jingjing Wang, et al.
Pubblicazione: (2025)

Pharmacokinetics and bioequivalence of two N‐acetylcysteine tablets in healthy Chinese volunteers under fasting and fed conditions
di: Xianmiao Yin, et al.
Pubblicazione: (2025)

Effect of High‐Fat Diets on the Pharmacokinetics of Bedaquiline Fumarate Tablet: A Trial in Healthy Chinese Participants
di: Xuanxuan Wang, et al.
Pubblicazione: (2025)